Issue Date | Title | Involved Person(s) |
2022 | Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis | Mattli, Renato; Grobet, Cécile; Sharakin, Maxim; Pöhlmann, Johannes; Vinci, Linda; Syleouni, Maria-Eleni; Carlander, Maria; Meier, Flurina; Egli, Philipp; Gerber-Grote, Andreas; Wieser, Simon |